Meet Athul, a sixth grader from Kerala who bravely manages Type 1 diabetes daily, carrying insulin and a glucometer to school ...

Cipla, a global leader in inhalation therapies, on Monday announced the launch of Afrezza, the world's only rapid-acting inhaled insulin, in the Indian market.

The insulin inhalation powder in Afrezza is available in single-use cartridges and is delivered via an inhaler device.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are ...

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

More GLP-1s aim to enter US market as Novo Nordisk, Eli Lilly, and Pfizer advance obesity treatments with FDA filings and trials.